Clin Mol Hepatol.
2024 Apr;30(2):284-286. 10.3350/cmh.2024.0108.
In response to: Steatotic liver disease-know your enemies
- Affiliations
-
- 1Larner College of Medicine at the University of Vermont, Burlington, VT, USA
- 2Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, USA
- 3Department of Epidemiology and Population Health, Stanford University Medical Center, Palo Alto, CA, USA
- KMID: 2554439
- DOI: http://doi.org/10.3350/cmh.2024.0108
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Steatotic liver disease: Know your enemies
- Waiting for the changes after the adoption of steatotic liver disease
- Similar respiratory function including chronic obstructive pulmonary disease between non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
- Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
- Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences
